GlassScriptPhysician profile
Don Richard Hess
NPI 1417984113
$1,075.39
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $250 · 2021: $337 · 2022: $87.02.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $183.06 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $142.70 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.22 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $94.97 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $87.87 | 2019-2020 | |
| Astellas Pharma US INC | $66.15 | 2019 | |
| Amgen INC. | $45.94 | 2021 | |
| Tersera Therapeutics LLC | $38.38 | 2019 | |
| Lilly USA, LLC | $34.55 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.16 | 2019-2022 | |
| Pfizer INC. | $31.73 | 2019-2021 | |
| Glaxosmithkline, LLC. | $24.85 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $23.38 | 2020 | |
| Abbvie INC. | $18.84 | 2021 | |
| Eisai INC. | $15.71 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.62 | 2020 | |
| Sanofi Pasteur INC. | $15.12 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.70 | 2021 | |
| Vyera Pharmaceuticals, LLC | $13.78 | 2019 | |
| Esperion Therapeutics, INC. | $13.45 | 2020 | |
| Genentech USA, INC. | $12.66 | 2019 | |
| Dexcom, INC. | $12.21 | 2021 | |
| Merck Sharp & Dohme LLC | $12.16 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.18 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.